Company Name |
LSI Medience Corporation |
Head office |
1-2-3 Shibaura, Minato-ku, Tokyo |
President and CEO |
Haruo Watanabe |
Paid-in capital |
3 billion yen |
Sales Revenue |
95.6 billion yen (as of March,2023) |
Primary Business Domains |
・Clinical testing (biochemical testing, hematological testing, immunological testing,
microbiological testing, genetic testing, pathological and other testing) |
・Medical services |
・Food Safety Support services |
・Anti-Doping test (sample analysis by WADA code) |
Number of employees (whole group) |
3,860 (as of March,2023) |
As of July.1,2023 |
Executives and Operating Executives |
Representative Director,Member of the Board President and Chief Executive Officer |
Haruo Watanabe |
Representative Director,Member of the Board Managing Director |
Satoru Kusunoki |
Member of the Board Managing Director |
Kenichi Uchino |
Member of the Board |
Koichiro Ota |
Member of the Board |
Kaiju Yamaguchi |
Executive Officer |
Takashi Kurihara |
Executive Officer |
Shinichi Jinno |
Executive Officer |
Akio Chino |
Executive Officer |
Nobuteru Matsuo |
Executive Officer |
Akira Myojo |
Executive Officer |
Junko Murase |
Executive Officer |
Masaru Yamada |
Audit & Supervisory Board Member |
Toshiyuki Itou |
Audit & Supervisory Board Member |
Yukinori Kishino |